MeiraGTx Holdings PLC (MGTX) - Total Assets
Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) holds total assets worth $244.43 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of MeiraGTx Holdings PLC to assess how comfortably operating cash covers total debt obligations.
MeiraGTx Holdings PLC - Total Assets Trend (2016–2025)
This chart illustrates how MeiraGTx Holdings PLC's total assets have evolved over time, based on quarterly financial data. See shareholders equity of MeiraGTx Holdings PLC for net asset value and shareholders' equity analysis.
MeiraGTx Holdings PLC - Asset Composition Analysis
Current Asset Composition (December 2025)
MeiraGTx Holdings PLC's total assets of $244.43 Million consist of 37.5% current assets and 62.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.0% |
| Accounts Receivable | $3.00 Million | 1.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $578.00K | 0.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how MeiraGTx Holdings PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is MeiraGTx Holdings PLC worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MeiraGTx Holdings PLC's current assets represent 37.5% of total assets in 2025, a decrease from 84.7% in 2016.
- Cash Position: Cash and equivalents constituted 27.0% of total assets in 2025, down from 77.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 1.2% of total assets.
MeiraGTx Holdings PLC Competitors by Total Assets
Key competitors of MeiraGTx Holdings PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
ALTEOGEN Inc
KQ:196170
|
Korea | ₩729.47 Billion |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
|
USA | $1.29 Billion |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX
|
USA | $440.10 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Galapagos N.V.
AS:GLPG
|
Netherlands | €3.37 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
MeiraGTx Holdings PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.75 | 2.03 | 4.30 |
| Quick Ratio | 0.75 | 2.03 | 4.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-30.79 Million | $62.73 Million | $176.61 Million |
MeiraGTx Holdings PLC - Advanced Valuation Insights
This section examines the relationship between MeiraGTx Holdings PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 225.31 |
| Latest Market Cap to Assets Ratio | 3.72 |
| Asset Growth Rate (YoY) | -9.4% |
| Total Assets | $244.43 Million |
| Market Capitalization | $909.07 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values MeiraGTx Holdings PLC's assets at a significant premium (3.72x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: MeiraGTx Holdings PLC's assets decreased by 9.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MeiraGTx Holdings PLC (2016–2025)
The table below shows the annual total assets of MeiraGTx Holdings PLC from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $244.43 Million | -9.39% |
| 2024-12-31 | $269.75 Million | -17.44% |
| 2023-12-31 | $326.74 Million | +2.67% |
| 2022-12-31 | $318.24 Million | -0.60% |
| 2021-12-31 | $320.16 Million | -11.97% |
| 2020-12-31 | $363.70 Million | +12.29% |
| 2019-12-31 | $323.89 Million | +234.27% |
| 2018-12-31 | $96.89 Million | +274.77% |
| 2017-12-31 | $25.85 Million | +14.65% |
| 2016-12-31 | $22.55 Million | -- |
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xe… Read more